Skip to main content

G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning.

Publication ,  Journal Article
Tong, H; Rockman, HA; Koch, WJ; Steenbergen, C; Murphy, E
Published in: Circ Res
April 30, 2004

The present study is designed to explore the role of G protein-coupled receptors (GPCRs) in the protection afforded by ischemic preconditioning (PC). We used TG mice with cardiac-specific overexpression of a Gbetagamma-sequestering peptide, betaARKct (TG betaARKct mice), to test whether the protection of PC is Gbetagamma-dependent. To test the role of G(i) protein, we used wild-type mice pretreated with the G(i) inhibitor pertussis toxin. Recovery of left ventricular developed pressure and infarct size were measured as indices of protection. PC induced protection in wild-type mice, but this protection was blocked by pertussis toxin treatment and was also blocked in TG betaARKct mice. To determine the mechanism of Gbetagamma-induced protection in PC, we investigated one of the downstream targets of Gbetagamma, the PI3K/p70S6K pathway. PC-induced phosphorylation of p70S6K was not blocked in TG betaARKct hearts; therefore, we investigated other targets of Gbetagamma. Recent studies suggest a role for Gbetagamma in GPCR internalization. We found that betaARKct, a specific PI3K inhibitor wortmannin, and bafilomycin A1, which all block receptor recycling, all blocked the protective effect of PC. To additionally test whether PI3K is involved in PC-activated receptor internalization and endosomal signaling, we used TG mice with cardiac-specific overexpression of a catalytically inactive mutant PI3Kgamma, which disrupts the recruitment of functional PI3K to agonist-activated GPCRs in vivo. We found that the catalytically inactive mutant of PI3Kgamma blocks the protection of PC. In summary, these data suggest the novel finding that the cardioprotective effect of PC requires receptor internalization.

Duke Scholars

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

April 30, 2004

Volume

94

Issue

8

Start / End Page

1133 / 1141

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Wortmannin
  • Recombinant Fusion Proteins
  • Protein Processing, Post-Translational
  • Phosphorylation
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphatidylinositol 3-Kinases
  • Pertussis Toxin
  • Myocardial Infarction
  • Mitogen-Activated Protein Kinases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tong, H., Rockman, H. A., Koch, W. J., Steenbergen, C., & Murphy, E. (2004). G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res, 94(8), 1133–1141. https://doi.org/10.1161/01.RES.0000126048.32383.6B
Tong, Haiyan, Howard A. Rockman, Walter J. Koch, Charles Steenbergen, and Elizabeth Murphy. “G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning.Circ Res 94, no. 8 (April 30, 2004): 1133–41. https://doi.org/10.1161/01.RES.0000126048.32383.6B.
Tong H, Rockman HA, Koch WJ, Steenbergen C, Murphy E. G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res. 2004 Apr 30;94(8):1133–41.
Tong, Haiyan, et al. “G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning.Circ Res, vol. 94, no. 8, Apr. 2004, pp. 1133–41. Pubmed, doi:10.1161/01.RES.0000126048.32383.6B.
Tong H, Rockman HA, Koch WJ, Steenbergen C, Murphy E. G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res. 2004 Apr 30;94(8):1133–1141.

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

April 30, 2004

Volume

94

Issue

8

Start / End Page

1133 / 1141

Location

United States

Related Subject Headings

  • beta-Adrenergic Receptor Kinases
  • Wortmannin
  • Recombinant Fusion Proteins
  • Protein Processing, Post-Translational
  • Phosphorylation
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphatidylinositol 3-Kinases
  • Pertussis Toxin
  • Myocardial Infarction
  • Mitogen-Activated Protein Kinases